Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This freeze-dried fecal microbiota transplantation (FMT) product is an investigational biological therapy developed by the Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. It is currently being evaluated in Phase II clinical trials for the treatment of recurrent urinary tract infections (rUTIs) in women. The therapy works by restoring the damaged intestinal ecosystem, increasing ecological diversity, and promoting the growth of commensal microorganisms. This ecological replacement aims to eliminate antibiotic-resistant pathogenic clones through intraspecific bacterial competition, providing a novel non-antibiotic alternative for managing recurrent infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on freeze-dried fecal microbiota (Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal).